CVS Health (CVS) Stock Forecast & Price Target
CVS Analyst Ratings
Strong Buy
16Buy0Hold0Sell
Based on 16 analysts giving stock ratings to CVS Health in the past 3 months
CVS Stock 12 Month Forecast
Average Price Target
MXN 2,139.27▲(25.54% Upside)Based on 16 Wall Street analysts offering 12 month price targets for CVS Health in the last 3 months. The average price target is MXN 2,139.27 with a high forecast of MXN 2,335.44 and a low forecast of MXN 1,999.14. The average price target represents a 25.54% change from the last price of MXN 1,704.00.
Past 12 Months12 Month ForecastDec2025Sep2026
HighMXN 2.34K
AverageMXN 2.14K
LowMXN 2K
Highest Price TargetHighestMXN 2,335.44Average Price TargetMXN 2,139.27Lowest Price TargetLowestMXN 1,999.14
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Allen Lutz | Bank of America Securities | MXN 2,055.19 | buy | 20.61%Upside | Reiterated | 10/13/26 | ||
| Michael Cherny | Leerink Partners | MXN 2,223.34→MXN 2,092.56 | buy | 22.80%Upside | Reiterated | 10/12/26 | ||
| Charles Rhyee | TD Cowen | MXN 2,055.19 | buy | 20.61%Upside | Reiterated | 10/09/26 | ||
| Ben Hendrix | RBC Capital | MXN 2,111.24 | buy | 23.90%Upside | Reiterated | 10/07/26 | ||
| Lance Wilkes | Bernstein | MXN 1,980.46→MXN 2,092.56 | buy | 22.80%Upside | Reiterated | 10/05/26 | ||
| Elizabeth Anderson CFA | Evercore ISI | MXN 2,335.44 | buy | 37.06%Upside | Reiterated | 10/02/26 | ||
| Stephen Baxter | Wells Fargo | MXN 2,298.08 | buy | 34.86%Upside | Reiterated | 09/15/26 | ||
| Kevin Caliendo | UBS | MXN 2,354.13→MXN 2,204.66 | buy | 29.38%Upside | Assigned | 09/03/26 | ||
| Brian Tanquilut | Jefferies | MXN 2,242.03 | buy | 31.57%Upside | Reiterated | 08/31/26 | ||
| Jessica Tassan | Piper Sandler | MXN 2,111.24 | buy | 23.90%Upside | Reiterated | 08/26/26 | ||
| Steven Silver | Argus Research | MXN 1,943.09→MXN 2,129.93 | buy | 25.00%Upside | Reiterated | 08/18/26 | ||
| Lisa Gill | J.P. Morgan | MXN 2,073.87→MXN 2,204.66 | buy | 29.38%Upside | Reiterated | 08/12/26 | ||
| Erin Wright | Morgan Stanley | MXN 2,073.87 | buy | 21.71%Upside | Assigned | 08/10/26 | ||
| Andrew Mok CFA | Barclays | MXN 1,980.46→MXN 2,017.82 | buy | 18.42%Upside | Reiterated | 08/06/26 | ||
| David S Macdonald | Truist Financial | MXN 2,204.66 | buy | 29.38%Upside | Reiterated | 08/06/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Allen Lutz | 10/13/26 | MXN 2,055.19 | buy | 20.61%Upside | Reiterated | Bank of America Securities | ||
| Michael Cherny | 10/12/26 | MXN 2,223.34→MXN 2,092.56 | buy | 22.80%Upside | Reiterated | Leerink Partners | ||
| Charles Rhyee | 10/09/26 | MXN 2,055.19 | buy | 20.61%Upside | Reiterated | TD Cowen | ||
| Ben Hendrix | 10/07/26 | MXN 2,111.24 | buy | 23.90%Upside | Reiterated | RBC Capital | ||
| Lance Wilkes | 10/05/26 | MXN 1,980.46→MXN 2,092.56 | buy | 22.80%Upside | Reiterated | Bernstein | ||
| Elizabeth Anderson CFA | 10/02/26 | MXN 2,335.44 | buy | 37.06%Upside | Reiterated | Evercore ISI | ||
| Stephen Baxter | 09/15/26 | MXN 2,298.08 | buy | 34.86%Upside | Reiterated | Wells Fargo | ||
| Kevin Caliendo | 09/03/26 | MXN 2,354.13→MXN 2,204.66 | buy | 29.38%Upside | Assigned | UBS | ||
| Brian Tanquilut | 08/31/26 | MXN 2,242.03 | buy | 31.57%Upside | Reiterated | Jefferies | ||
| Jessica Tassan | 08/26/26 | MXN 2,111.24 | buy | 23.90%Upside | Reiterated | Piper Sandler | ||
| Steven Silver | 08/18/26 | MXN 1,943.09→MXN 2,129.93 | buy | 25.00%Upside | Reiterated | Argus Research | ||
| Lisa Gill | 08/12/26 | MXN 2,073.87→MXN 2,204.66 | buy | 29.38%Upside | Reiterated | J.P. Morgan | ||
| Erin Wright | 08/10/26 | MXN 2,073.87 | buy | 21.71%Upside | Assigned | Morgan Stanley | ||
| Andrew Mok CFA | 08/06/26 | MXN 1,980.46→MXN 2,017.82 | buy | 18.42%Upside | Reiterated | Barclays | ||
| David S Macdonald | 08/06/26 | MXN 2,204.66 | buy | 29.38%Upside | Reiterated | Truist Financial |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering CVS Health
3 Months
Success Rate15/20 ratings generated profit
75%
Average Return
+12.01%
Copying Stephen Baxter's trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +12.01% per trade.
1 Year
Success Rate17/20 ratings generated profit
85%
Average Return
+27.68%
Copying Stephen Baxter's trades and holding each position for 1 Year would result in 85.00% of your transactions generating a profit, with an average return of +27.68% per trade.
2 Years
Success Rate25/29 ratings generated profit
86%
Average Return
+34.14%
Copying Allen Lutz's trades and holding each position for 2 Years would result in 86.21% of your transactions generating a profit, with an average return of +34.14% per trade.
CVS Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 34 | 37 | 36 | 35 | 32 |
| Hold | 0 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 34 | 38 | 37 | 36 | 32 |
In the current month, CVS has received 32 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CVS average Analyst price target in the past 3 months is 2,139.27.
CVS Financial Forecast
HighMXN 34.75
ConsensusMXN 30.71
LowMXN 28.24
CVS Earnings Forecast
Next quarter’s earnings estimate for CVS is MXN 30.71 with a range of MXN 28.24 to MXN 34.75. The previous quarter’s EPS was MXN 47.94. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighMXN 2.02T
ConsensusMXN 1.95T
LowMXN 1.9T
CVS Sales Forecast
Next quarter’s sales forecast for CVS is MXN 1.95T with a range of MXN 1.90T to MXN 2.02T. The previous quarter’s sales results were MXN 1.97T. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
CVS Stock Forecast FAQ
What is MX:CVS’s average 12-month price target, according to analysts?
Based on analyst ratings, CVS Health’s 12-month average price target is Mex$2,139.27.
What is MX:CVS’s upside potential, based on the analysts’ average price target?
CVS Health has 25.54% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CVS Health a Buy, Sell or Hold?
CVS Health has a consensus rating of Strong Buy, which is based on 16 buy ratings, 0 hold ratings and 0 sell ratings.
What is CVS Health’s share price target?
The average share price target for CVS Health is Mex$2,139.27. This is based on 16 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$2,335.44, and the lowest forecast is Mex$1,999.14. The average share price target represents a 25.54% increase from the current price of Mex$1,704.
What do analysts say about CVS Health?
CVS Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 16 Wall Street analysts.
How can I buy shares of CVS Health?
To buy shares of MX:CVS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
